Lamotrigine and seizure aggravation in severe myoclonic epilepsy

Epilepsia

Volumn 39, Issue 5, 1998, Pages 508-512

  Guerrini, Renzo ^a,d   Dravet, Charlotte ^b   Genton, Pierre ^b   Belmonte, Anna ^a   Kaminska, Anna ^c   Dulac, Olivier ^c  

^a UNIVERSITY OF PISA   (Italy)

^b CENTRE SAINT PAUL   (France)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

^d Scientific Institute of Child Neurology and Psychiatry   (Italy)

Author keywords

Lamotrigine; Seizure worsening; Severe myoclonic epilepsy

Indexed keywords

LAMOTRIGINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FACILITATION; FEMALE; HOSPITALIZATION; HUMAN; MALE; MYOCLONUS EPILEPSY; PHOTOSENSITIVITY; PRIORITY JOURNAL; SEIZURE;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; COMORBIDITY; DRUG THERAPY, COMBINATION; EPILEPSIES, MYOCLONIC; EPILEPSIES, PARTIAL; EPILEPSY, GENERALIZED; FEMALE; HUMANS; MALE; TRIAZINES;

EID: 0031947590     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1998.tb01413.x     Document Type: Article

References (37)

1. Dravet C, Bureau M, Guerrini G, Giraud N, Roger J. Severe myoclonic epilepsy in infants. In; Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P, eds. Epileptic syndromes in infancy, childhood and adolescence. 2nd ed. London: John Libbey, 1992: 75-88.
2. Guerrini R, Dravet C, Severe epileptic encephalopathies of infancy, other than West syndrome. In: Engel J, Pedley TA, eds. Epilepsy: a comprehensive textbook, Philadelphia: Lippincott- Raven, 1997:2285-302.
3. Gou KL, Ross SR, Chrisp P. Lantotrigine: a review of its pharmacological properties and clinical efficacy in epilepsy. Drills 1993; 46:152-76.
4. Besag FMC, Wallace SJ, Dulac O, Alving J, Spencer SC, Hosking G. Lamotrigine for the treatment of epilepsy in childhood. J Pediatr 1995;127:991-7.
5. Bartoli A, Guerrini R, Belmonte A, Alessandrì MG, Gatti G, Perucca E. The influence of dosage, age, and comedication on steady- state plasma lamotrigine concentrations in epileptic children: a prospective study with preliminary assessment of correlations with clinical response. Ther Drug Monit 1997;19:100-7.
6. Veggiotti P, Cieuta C, Rex E, Dulac O, Lamotrigine in infantile spasms. Lancet 1994;344:1375-6.
7. Schlumberger E, Chavez F, Palacios L, Rey E, Pajot N, Dulac O. Lamotrigine in the treatment of 120 children with epilepsy. Epilepsia 1994;35:359-67.
8. Oller LFV, Russi A, Daurella L. Lamotrigine in Lennoxx-Gastaut syndrome, Epilepsia 1991;31(suppl 1):58.
9. Timmings PL, Richens A. Lamotrigine as an add-on drug in the management of Lennox-Gastaut syndrome, Eur Neurol 1992;32: 305-7.
10. Mullens L, Gallagher J, Manasco P. for The Lamictal Lennox- Gastaut Study Group. Improved neurological fuction accompanies effective control of the Lennox-Gastaut syndrome with Lamictal: results of a multinational placebo-controlled trial. Epilepsia 1996;37(suppl 5):163.
11. Billard C, Motte J, Arvidsson D, et al. Double-blind, placebo- controlled evaluation of the safety and efficacy of lamotrigine (Lamictal) for the treatment of patients with a clinical diagnosis of Lennox-Gastaut syndrome. Epilepsia 1996;37(suppl 4):92.
12. Genton P, Dravet C, Bureau N, Formosa F, Mesdjian E. Aggravation of severe myoclonic epilepsy of infants by lamotrigine. Epilepsia 1997;38(suppl 3):32.
13. Bauer J. Seizure-inducing effects of antiepileptic drugs: a review. Acta Neurol Scand 1996;94;367-77.
14. Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening of seizures, Epilepsia (in press).
15. Horn CS, Ater SB, Hurst DL. Carbamazepine-exacerbaied epilepsy in children and adolescents. Pediatr Neural 1986;2:340-5.
16. Wakai S, Ito N, Sucoka H, Kawamoto Y, Hayasa H, Chiba S. Severe myoclonic epilepsy in infancy and carbamazepine. Eur J Pediatr 1996;155:724.
17. Ahnut H, Ashman P, Feuerstein TJ, Sauermann W, Saunders M, Schmidt B, for the International Gabapentin Study Group. Gabapentin (Neurontin) as add-on therapy in patients with pantial seizures: a double-blind, placebo-Controlled study. Epilepsia 1994; 35:795-801.
18. Genton, P, Guerrini R, Roger J. Treatment of epitepsy in children and adults with multiple handicaps. In: Shorvon S, Dreifuss F, Fish D, Thomas D, eds. The treatment of epilepsy. London: Blackwell Science, 1996:215-26.
19. Sander JWAS, Hart YM, Patsalos PN, Duncan JS, Shorvon SD. Lamotrigine and generalized seizures. Epilepsia 1991;32(suppl 1): 59.
20. Gibbs J, Appleton RE, Rosenbloom L, Yuen WC. Lamotrigine for intractable childhood epilepsy: a preliminary communication. Dev Med Child Neurol 1992;34:368-71.
21. Timmings PL, Richens A. Efficacy of lamotrigine as monotherapy for juvenile myoclonic epilepsy: pilot study results. Epilepsia 1993;34(suppl 2):160.
22. Ferrie CD, Robinson RO, Knott C, Panayiotopoulos CP. LTG as add-on drug in typical absence seizures. Acta Neurol Scand 1994; 91:000-2.
23. Renier WO, Renkawek K. Clinical and neuropathological findings in a case of severe myoclonic epilepsy of infancy. Epilepsia 1990; 31:287-91.
24. Perucca E. The new generation of antiepileptic drugs: advantages and disadvantages. Br J Clin Pharmacol 1996;42:531-3.
25. Dalla Bernardina B, Capovilla B, Gattoni G, et al. Epilepsie myoclonique grave de la premiére année, Rev EEG Neurophysiol 1982; 12:21-5.
26. Dulac O, Arthuis M. L'épilepsie myoclonique sévère de l'enfant. In: Journées parisiennes de pédiatrie. Paris: Flammarion, 1982: 259-68.
27. Ogino T. Ohtsuka Y, Yamatogi Y, Oka E, Ohtahara S, Severe myoclonic epilepsy in infancy: clmico-electroencephalographic and long-term follow up studies. Brain Dev 1986;8:162.
28. Sugama M, Oguni H, Fukuyama Y. Clinical and electroencepha- lographic study of severe myoclonic epilepsy in infancy. Jpn J Psychiatr Neurol 1987;41:463-5.
29. Hurst DL. Severe myoclonic epilepsy in infancy. Pediatr Neurol 1987;3:269-72.
30. Musumeci SA, Elia M, Ferri R, et al. Epilessia mioclonica grave in due gemelli monozigoti con sindrome di Rud. Boll Lega Ital Epil 1992;79/80:81-2.
31. Fujiwara T. Nakamura H, Watanabe M, et al. Clinicoelectrographic concordance between monozygotic twins with severe myoclonic epilepsy in infancy, Epilepsia 1990;31:281-6.
32. Timmings PL, Richens A. Lamotrigine in primary generalized epilepsy. Lancet 1992;339:1300.
33. Gram L. Treatment of typical absences: acetazolamide, benzodiazepines and lamotrigine. In: Duncan JS, Panayiotopoulos CP, eds. Typical absences and related epileptic syndromes. London: Churchill Communications Europe, 1995:368-75.
34. Dravet C. Controlled trials in nonprogressive myoclonic epilepsies. In: Fejerman N, Chamoles NA, eds. New trends in pediatric neurology. Amsterdam: Excerpta Medica, 1993:283-9.
35. Shields WD, Saslow E. Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology 1983;33:1487-9.
36. Carter Snead O, Hosey LC. Exacerbation of seizures in children by carbamazepine. N Engl J Med 1985;313:916-21.
37. Guerrini R, Paglia G, Dravet C, et al. Efficacy of vigabatrin as add-on therapy in relation to type of epilepsy or epileplic syndrome: retrospective study of 120 patients. Epilepsia 1994;35 (suppl 7):65.